The coupling of NO and IGF-1 metabolic and signaling pathways might highlight early markers, such as the inhibition of NOS measured as a lower Arg/ADMA ratio in our CF patients, for growth hormone deficiencies and nutritional failure. This evidence concerns the gene GH1 and cystic fibrosis.